Skip to main content

Table 1 Characteristics of autism tissue samples

From: Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid

Sample ID# CASE # Age (years) Gender PMI (hours) Primary cause of death ADI-R Drug treatment history
A1 AN01093 56 Male 19.48 Anoxic Encephalopathy 48 N/A
A2 UMB1174 7 Female 14 Seizure, Hypotension 44 Depakote, Dilantin, Tegretol
A3 AN00764 20 Male 23.7 Auto Trauma 50 Minocin
A4 AN08792 30 Male 20.3 GastroIntestinal Bleeding 41 Phenobarbital, Mysoline, Dilantin, Depakote, Cisapride, Clorazepate, Prolosec, Propulsid, Reglan, Tranxene
A5 AN06420 39 Male 13.95 Cardiac Tamponade 41 Synthroid, Depakote, Risperidol, Paxil, Blood pressure medication
A6 AN00493 27 Male 8.3 Drowning - Synthroid
A7 AN08873 5 Male 25.5 Asphyxia Due To Drowning 47 Prozac
A8 UMB797 9 Male 13 Drowning 50 Desipramine
A9 UMB1182 9 Female 24 Smoke Inhalation - N/A
A10 AN16641 9 Male 27 Seizure Disorder 46 Clonidine, Depakote, Dilantin, Lamictal, Ritalin, Tegretol
A11 AN16115 11 Female 12.88 Seizure & Drowning in Tub 44 Adderall, Dexadrine, Dilantin, Klonopin, Lamictal, Tegretol, Topomax
  Mean 20.1   18.3    
  SEM (+/−) 4.9   1.8    
  1. N/A = Information Not Available; PMI = Post Mortem Interval; ADI-R = Autism Diagnostic Interview-Revised.